Filing date Form Description Filing Group Issuer View
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
Crinetics Pharmaceuticals, Inc. EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
Crinetics Pharmaceuticals, Inc. View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
Crinetics Pharmaceuticals, Inc. View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
Crinetics Pharmaceuticals, Inc. View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
Crinetics Pharmaceuticals, Inc. View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
Crinetics Pharmaceuticals, Inc. View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
Crinetics Pharmaceuticals, Inc. View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
Crinetics Pharmaceuticals, Inc. View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
Crinetics Pharmaceuticals, Inc. View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
Crinetics Pharmaceuticals, Inc. View HTML

Data provided by Kaleidoscope.

Contact


Contact